GLP-1 Agonists Can Affect Mood: A Case of Worsened Depression on Ozempic (Semaglutide).
1 Citations•2024•
Senthil Vel Rajan Rajaram Manoharan, Rohit Madan
Innovations in clinical neuroscience
This case report underscores the adverse mood changes possibly linked to semaglutide and the need for further study in this area.
Abstract
Glucagon-like peptide-1 (GLP-1) receptor agonists have garnered significant attention in diabetes management, and they act by mimicking the effects of GLP-1, a hormone that regulates insulin secretion and appetite. While these medications have become increasingly popular, their impact on mood and other psychiatric manifestations remains uncertain because of inconsistent data. It has been shown to affect brain regions involved in emotional regulation. This case report underscores the adverse mood changes possibly linked to semaglutide and the need for further study in this area.